mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Predicted mutations | |||||
|---|---|---|---|---|---|
| evidence | position | mutation | annotation | gene | description |
| RA | 49,910 | T→G | W30G (TGG→GGG) | folA → | type 3 dihydrofolate reductase |
| RA | 1,613,393 | A→T | D6V (GAT→GTT) | marR → | multiple antibiotic resistance transcriptional regulator MarR |
| MC JC | 2,399,465 | Δ7 bp | coding (650‑656/939 nt) | lrhA ← | transcriptional regulator LrhA |
| RA | 3,511,988 | C→A | E146* (GAG→TAG) | aroK ← | shikimate kinase AroK |
| Unassigned missing coverage evidence | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| seq id | start | end | size | ←reads | reads→ | gene | description | |||
| * | * | ÷ | NZ_CP009273 | 356981 | 357568 | 588 | 4 [0] | [1] 5 | lacA | galactoside O‑acetyltransferase |
| * | * | ÷ | NZ_CP009273 | 578688 | 578716 | 29 | 4 [2] | [2] 3 | BW25113_RS26085/appY | tail fiber assembly protein/DNA‑binding transcriptional activator AppY |
| * | * | ÷ | NZ_CP009273 | 1459470 | 1459491 | 22 | 3 [1] | [2] 4 | [BW25113_RS25580] | [BW25113_RS25580] |
| * | * | ÷ | NZ_CP009273 | 1524325 | 1524432 | 108 | 3 [2] | [2] 3 | [BW25113_RS26145] | [BW25113_RS26145] |
| * | * | ÷ | NZ_CP009273 | 1631968 | 1632043 | 76 | 3 [2] | [2] 3 | [gnsB] | [gnsB] |
| * | * | ÷ | NZ_CP009273 | 1972752 | 1972760 | 9 | 38 [0] | [2] 5 | flhD/uspC | flagellar transcriptional regulator FlhD/universal stress protein UspC |
| * | * | ÷ | NZ_CP009273 | 2779873 | 2779883 | 11 | 3 [0] | [2] 3 | BW25113_RS26005 | alpha‑amylase family glycosyl hydrolase |
| Unassigned new junction evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NZ_CP009273 | = 287112 | NA (NA) | 17 (0.540) | 15/166 | 0.6 | 85.0% | intergenic (‑55/‑99) | BW25113_RS01405/BW25113_RS01410 | IS1‑like element IS1B family transposase/hypothetical protein |
| ? | NZ_CP009273 | 1903038 = | 3 (0.090) | intergenic (‑15/‑144) | mgrB/yobH | PhoP/PhoQ regulator MgrB/YobH family protein | |||||
| * | ? | NZ_CP009273 | 360104 = | NA (NA) | 89 (2.800) | 35/166 | 0.0 | NA | intergenic (‑35/+251) | lacZ/BW25113_RS23320 | beta‑galactosidase/relaxase/mobilization nuclease domain‑containing protein |
| ? | NZ_CP009273 | = 360286 | NA (NA) | intergenic (‑217/+69) | lacZ/BW25113_RS23320 | beta‑galactosidase/relaxase/mobilization nuclease domain‑containing protein | |||||
| * | ? | NZ_CP009273 | = 1046001 | NA (NA) | 27 (0.850) | 21/166 | 0.3 | 93.1% | intergenic (+15/+418) | BW25113_RS05135/cspH | IS1‑like element IS1D family transposase/cold shock‑like protein CspH |
| ? | NZ_CP009273 | = 1903046 | 2 (0.060) | intergenic (‑23/‑136) | mgrB/yobH | PhoP/PhoQ regulator MgrB/YobH family protein | |||||
| * | ? | NZ_CP009273 | 1203246 = | 8 (0.250) | 8 (0.310) | 8/134 | 1.1 | 50.9% | coding (290/630 nt) | BW25113_RS05990 | hypothetical protein |
| ? | NZ_CP009273 | 1205075 = | 9 (0.350) | coding (40/540 nt) | BW25113_RS06005 | phage tail protein | |||||
| * | ? | NZ_CP009273 | = 1203261 | 8 (0.250) | 7 (0.270) | 6/134 | 1.4 | 47.6% | coding (305/630 nt) | BW25113_RS05990 | hypothetical protein |
| ? | NZ_CP009273 | = 1205058 | 9 (0.350) | coding (57/540 nt) | BW25113_RS06005 | phage tail protein | |||||
| * | ? | NZ_CP009273 | = 1972751 | 0 (0.000) | 38 (1.200) | 23/166 | 0.2 | 100% | intergenic (‑297/‑483) | flhD/uspC | flagellar transcriptional regulator FlhD/universal stress protein UspC |
| ? | NZ_CP009273 | = 2283592 | NA (NA) | intergenic (‑68/‑387) | BW25113_RS11435/narP | IS5‑like element IS5 family transposase/nitrate/nitrite response regulator protein NarP | |||||